Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Glioblastoma multiforme - Tractament"'
Autor:
Maria Vieito, Matteo Simonelli, Filip de Vos, Victor Moreno, Marjolein Geurts, Elena Lorenzi, Marina Macchini, Martin J van den Bent, Gianluca Del Conte, Maja de Jonge, Maria Cruz Martín-Soberón, Barbara Amoroso, Tania Sanchez-Perez, Marlene Zuraek, Bishoy Hanna, Ida Aronchik, Ellen Filvaroff, Henry Chang, Cristina Mendez, Marina Arias Parro, Xin Wei, Zariana Nikolova, Juan Manuel Sepulveda
Publikováno v:
Neuro-Oncology Advances, 4(1):vdac146. Oxford University Press
Scientia
Scientia
Background Standard-of-care treatment for newly diagnosed glioblastoma (ndGBM), consisting of surgery followed by radiotherapy (RT) and temozolomide (TMZ), has improved outcomes compared with RT alone; however, prognosis remains poor. Trotabresib, a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f12eaafe59322f3b7697cccec754b55
https://pure.eur.nl/en/publications/8c7f43ea-d16a-4ab8-9cbc-301f4b9a0462
https://pure.eur.nl/en/publications/8c7f43ea-d16a-4ab8-9cbc-301f4b9a0462
Autor:
Balsa Pena, Mario
Publikováno v:
Medicina (TFG)
DUGiDocs – Universitat de Girona
instname
DUGiDocs – Universitat de Girona
instname
BACKGROUND: glioblastoma multiforme is the most common primary malignant tumor of the central nervous system in adults. In our environment, the incidence is 4.17 (95% CI 3.80- 4.57) cases per 100.000 inhabitants/year, with a global survival per year
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::129d1e95d5b2047e710eccf6caf2ad51
http://hdl.handle.net/10256/18501
http://hdl.handle.net/10256/18501